Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Steminent Biotherapeutics, Inc. (7729) Financial Statements

Steminent Biotherapeutics, Inc. Financial Overview

Steminent Biotherapeutics, Inc.'s market cap is currently NT$19.93B. The company's EPS TTM is NT$-3.03; its P/E ratio is -44.07; Steminent Biotherapeutics, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 0.00NT$ 941.00KNT$ 636.00KNT$ 2.12M
Gross ProfitNT$ -30.92MNT$ -16.43MNT$ -1.04MNT$ -8.93MNT$ -1.75M
Operating IncomeNT$ -172.87MNT$ -162.29MNT$ -131.46MNT$ -98.21MNT$ -75.59M
EBITDANT$ -142.74MNT$ -140.26MNT$ -115.39MNT$ -75.15MNT$ -111.54M
Net IncomeNT$ -174.04MNT$ -158.75MNT$ -129.23MNT$ -85.47MNT$ -124.20M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 499.18MNT$ 217.00MNT$ 451.86MNT$ 153.43MNT$ 230.56M
Total AssetsNT$ 698.49MNT$ 436.66MNT$ 593.88MNT$ 235.65MNT$ 279.50M
Total DebtNT$ 77.42MNT$ 63.78MNT$ 75.38MNT$ 55.16MNT$ 19.17M
Net DebtNT$ -421.76MNT$ -141.63MNT$ -376.48MNT$ -98.27MNT$ -211.39M
Total LiabilitiesNT$ 97.34MNT$ 81.97MNT$ 100.89MNT$ 72.11MNT$ 35.23M
Stockholders' EquityNT$ 601.15MNT$ 354.70MNT$ 492.99MNT$ 163.54MNT$ 244.27M
Cash Flow
Free Cash FlowNT$ -140.07MNT$ -227.79MNT$ -142.52MNT$ -71.71MNT$ -55.71M
Operating Cash FlowNT$ -132.31MNT$ -139.41MNT$ -114.81MNT$ -69.20MNT$ -55.11M
Investing Cash FlowNT$ 3.84MNT$ -99.97MNT$ -28.56MNT$ -2.50MNT$ -548.00K
Financing Cash FlowNT$ 422.52MNT$ -7.49MNT$ 441.95MNT$ -5.43MNT$ 245.42M

Currency in TWD

Steminent Biotherapeutics, Inc. Earnings and Revenue History

-200M-100M0100M-15000 %-10000 %-5000 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Steminent Biotherapeutics, Inc. Liabilities to Assets

0250M500M750M0 %40 %80 %120 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Steminent Biotherapeutics, Inc. Cash Flow

-200M0200M400M600M202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Steminent Biotherapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >